- Last Price0.01
- All-Time High2.21
- Total Supply2.00B
- Turnover (24h)337.05K
- All-Time Low0.0083
Learned by 24 usersPublished on 2025.06.30Last updated on 2025.06.30
0.01
+2.77%Note: The project description is sourced from official materials provided by the project team. However, it is important to note that these materials may be outdated, contain errors, or omit certain details. The provided content is for reference purposes only and should not be considered investment advice. HTX does not assume any liability for any direct or indirect losses incurred as a result of relying on this information.
This report provides an in-depth examination of two distinct blockchain initiatives: IRISnet (IRIS) and IRIS Chain (IRC). IRISnet operates as a decentralised service protocol built on Cosmos SDK/Tendermint infrastructure, focusing on cross-chain interoperability and enterprise application development. Meanwhile, IRIS Chain represents a specialised healthcare blockchain leveraging iris biometrics for personalised health management, utilising its native IRC token. Both projects demonstrate innovative approaches to blockchain implementation—IRISnet through its service-oriented architecture enabling business integration, and IRIS Chain through its fusion of biometric technology with decentralised health data management. The following analysis explores their technical architectures, founding teams, investment ecosystems, operational mechanisms, and developmental trajectories.
IRISnet functions as a regional hub within the Cosmos ecosystem, designed to facilitate distributed business applications through enhanced interoperability. Its architecture enables seamless coordination between on-chain transactions and off-chain data processing, serving as a bridge between conventional business systems and blockchain technology. The platform's core mission involves creating an open infrastructure where enterprises can deploy interoperable services across heterogeneous systems, including public chains, consortium chains, and legacy infrastructure.
The project was co-founded by Harriet Cao and Haifeng Xi through Bianjie AI, a Shanghai-based technology firm specialising in blockchain solutions. Cao brings extensive experience in computer science and blockchain architecture, while Xi contributes expertise in artificial intelligence systems. Development oversight includes collaboration with Tendermint Core engineers, ensuring alignment with Cosmos ecosystem standards. The team maintains a decentralised governance model where IRIS token holders participate in protocol evolution through voting mechanisms.
IRISnet employs a layered architecture comprising:
Notably, the network supports multi-token systems where validators can accept whitelisted tokens from connected chains, enhancing payment flexibility. The infrastructure also includes SDKs for service development and a smart wallet enabling cross-chain asset management.
IRIS Chain represents a specialised blockchain application in healthcare, utilising iris recognition technology to create personalised health management systems. The platform converts iris biometric data—which contains intrinsic health indicators—into blockchain-secured information, enabling users to monitor chronic conditions and access predictive health analytics. Core innovation lies in its GDPR-compliant approach to sensitive health data, where decentralised storage eliminates centralised vulnerability points while maintaining patient privacy.
The project features a multinational technical team including AI specialist Mr. Yeom, financial architect Matsuoka Hideo, and blockchain engineer Sakamoto Taro. Development is spearheaded by an undisclosed entity, with $20 million Series A funding secured in 2025 through Black Diamond's investment leadership. This capital injection supports global deployment of the IRIS App ecosystem, which integrates iris authentication with digital health services.
The platform operates through three interconnected components:
This architecture enables real-time health monitoring while maintaining data sovereignty through cryptographic ownership controls. The system currently processes “tens of millions” of health assessments through hospital partnerships in Asia, with planned expansion into Western markets.
While both projects utilise blockchain fundamentals, their consensus approaches differ significantly. IRISnet employs delegated Proof-of-Stake (dPoS) where token holders delegate validation rights to specialised nodes, balancing decentralisation with enterprise-grade throughput. Conversely, IRIS Chain utilises a permissioned blockchain model where healthcare providers and accredited institutions maintain validator nodes, prioritising regulatory compliance over full decentralisation.
The IRIS token primarily facilitates network operations (staking, fees, governance), functioning as a multi-purpose utility instrument within its ecosystem. IRC tokens exhibit specialised utility focused exclusively on health service access, data sharing permissions, and contributor rewards within the healthcare ecosystem. This reflects divergent tokenomic philosophies: IRIS token as infrastructure fuel versus IRC token as specialised service key.
IRISnet demonstrates maturation toward becoming a foundational interoperability layer for business blockchain integration. Future development will likely focus on:
The healthcare project shows significant near-term growth potential through:
Both projects represent specialised blockchain implementations addressing distinct sectoral needs—IRISnet in enterprise interoperability and IRIS Chain in healthcare innovation. Their continued evolution will likely influence cross-chain service architectures and biometric data applications respectively, contributing to broader blockchain adoption across industries.
11/07 02:17
11/07 02:18
11/07 02:18
11/07 02:17
11/07 02:18
Discussions
Welcome to the HTX Community. Here, you can stay informed about the latest platform developments and gain access to professional market insights. Users' opinions on the price of IRC (IRC) are presented below.